Oncogenic Transformation by Inhibitor-Sensitive and -Resistant EGFR Mutants.
Greulich H, Chen TH, Feng W, Janne PA, Alvarez JV, Zappaterra M, Bulmer SE, Frank DA, Hahn WC, Sellers WR, Meyerson M
PLoS Med. 2005 Oct 4. 2(11):e313.
(Link opens in a new window)
PubMed
(Link opens in a new window)
Article
Plasmids from Article
| ID | Plasmid | Purpose |
|---|---|---|
| 11011 | EGFR WT | Retroviral construct for expressing human EGFR in human cells |
| 11012 | EGFR L858R | Retroviral construct for expressing human EGFR with L858R mutation in human cells |
| 11013 | EGFR G719S | Retroviral construct for expressing human EGFR with G719S mutation in human cells |
| 11014 | EGFR D837A | Retroviral construct for expressing human EGFR with D837A mutation in human cells |
| 11015 | EGFR (del3) L747-E749del, A750P | Retroviral construct for expressing human EGFR with L747-E749 deletion and A750P mutation in human cells |
| 11016 | EGFR D770-N771 insNPG | Retroviral construct for expressing human EGFR with D770-N771 insNPG mutation in human cells |